Elravie HA – Advanced Cross-Linked Fillers from Korea

Product Overview

Elravie is the first monophasic cross-linked sodium hyaluronate (HA) gel injectable in Korea, setting a new milestone in aesthetic medicine. With breakthrough technology, Elravie surpasses conventional HA fillers by offering 2–3 times higher viscosity and a cross-linking rate of up to 12%, delivering superior volumizing effect, shape stability, and long-lasting results. The product has received authoritative certifications, including CFDA, KFDA, and CE.

Elravie’s unique formulation ensures smooth post-injection integration, minimizing displacement or migration while maintaining natural contours and long-term efficacy.

Product Variants

1. Elravie Ultra Volume – Large Molecular HA

• Indication: Facial contouring, enhancing chin, jawline, and forehead volume

• Molecular Weight: High viscosity, optimized for maximum projection and structural support

• Specification: 1 mL/ syringe, 1 syringe per box

• Needle: 25G

• HA Concentration: 23 mg/mL

• Lidocaine: 0.3%

• Injection Depth & Areas: Deep subcutaneous/structural injection; ideal for brow arches, chin, and nasal bridge

• Recommended Dosage: Chin: 2–3 syringes; Nose: 1–2 syringes; Brow: 1–2 syringes

• Storage: 1–30°C, avoid freezing, store in a cool place

• Duration: 12–18 months

2. Elravie Deep Line – Medium Molecular HA

• Indication: Soft tissue volumizing, deep wrinkles, facial contour enhancement

• Specification: 1 mL/ syringe, 1 syringe per box

• Needle: 27G

• HA Concentration: 23 mg/mL

• Lidocaine: 0.3%

• Injection Depth & Areas: Deep subcutaneous; suitable for chin, nose, temples, cheeks, forehead, nasolabial folds, and malar regions

• Recommended Dosage: Temples: 3–6 syringes; Forehead: 4–12 syringes; Cheeks: 4–10 syringes; Nasolabial folds: 2–6 syringes; Malar: 2–4 syringes

• Storage: 1–30°C, avoid freezing, store in a cool place

• Duration: 12–18 months

3. Elravie Light – Small Molecular HA

• Indication: Fine line correction, superficial wrinkles, delicate facial areas

• Specification: 1 mL/ syringe, 1 syringe per box

• Needle: 30G

• HA Concentration: 23 mg/mL

• Lidocaine: 0.3%

• Injection Depth & Areas: Epidermal and superficial dermis; ideal for tear troughs, lips, under-eye “aegyo-sal,” and other fine lines

• Recommended Dosage: Tear troughs: 1–2 syringes; Lips: 1–2 syringes; Under-eye: 1–2 syringes

• Storage: 1–30°C, avoid freezing, store in a cool place

• Duration: 8–12 months

Key Features & Benefits

• Large Molecular HA: Provides high structural support, ideal for contouring and volumizing

• Medium Molecular HA: Soft yet supportive, suitable for deep wrinkle correction and soft tissue augmentation

• Small Molecular HA: Gentle, precise filler for superficial lines and delicate areas

• Enhanced Viscosity & Cross-Linking: Ensures long-lasting results with minimal product migration

• Lidocaine Integration: Provides comfort during injections for a more patient-friendly experience

• Clinically Validated: Safe, effective, and CE/KFDA/CFDA certified

Clinical Insight

Elravie HA fillers provide a comprehensive solution for facial rejuvenation and volumization, from deep structural correction to delicate fine-line smoothing. Its high viscosity and controlled cross-linking offer reliable outcomes for both professionals and patients seeking natural-looking, long-lasting enhancements. Whether for facial contouring, wrinkle reduction, or volumizing, Elravie represents a breakthrough in precision aesthetic injections.